Related Experiment Videos
Immunolocalization of platelet-derived growth factor, transforming growth factor-beta, and fibronectin in acute
M Kitagawa1, S Yoshida, I Ishige
1Department of Pathology, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
Abstract:
Acute megakaryoblastic leukemia (AMKL) manifesting myelofibrosis and tumor formation in the liver with marked increase of reticulin is described. The megakaryoblastic nature of the leukemic cells of the bone marrow and the hepatic tumor nodule was established by positive immunohistochemical stains for CD41a and CD41b on frozen tissue sections. Immunolocalization of the platelet-derived growth factor (PDGF) protein and transforming growth factor (TGF)-beta protein also was demonstrated in the leukemic cells of the bone marrow and the hepatic tumor. Further, the deposition of fibronectin that has been known as the ligand of CD41a molecule and collagen types I and IV were recognized in the extracellular matrix of the bone marrow and the hepatic tumor. These results suggest that specific expression of growth factor proteins by the leukemic cells may selectively regulate the fibrosis of the bone marrow as well as the tumor formation of AMKL. The expression of adhesion molecules and growth factor proteins by the leukemic cells and the deposition of extracellular matrix are discussed in relation to the myelofibrosis as well as the tumor-forming nature of AMKL.
Insights
This study describes acute megakaryoblastic leukemia (AMKL) with liver tumors and bone marrow fibrosis. Leukemic cells express growth factors, potentially driving tumor formation and fibrosis in AMKL.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia.
- AMKL can present with extramedullary manifestations, including liver involvement.
- Myelofibrosis, a condition characterized by bone marrow scarring, can complicate leukemias.
Observation:
- This case report details an AMKL patient with concurrent myelofibrosis and hepatic tumor formation.
- Immunohistochemical analysis confirmed the megakaryoblastic nature of leukemic cells in both bone marrow and liver.
- Leukemic cells expressed platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β).
Findings:
- Fibronectin and collagen types I and IV were deposited in the extracellular matrix of the bone marrow and liver tumor.
- The expression of CD41a, a fibronectin ligand, was observed on leukemic cells.
- Specific growth factor proteins (PDGF, TGF-β) were identified within the leukemic cells.
Implications:
- Leukemic cell expression of growth factors may play a crucial role in regulating myelofibrosis and tumor formation in AMKL.
- Understanding these molecular mechanisms could lead to targeted therapies for AMKL.
- This case highlights the complex interplay between leukemic cells, extracellular matrix, and microenvironment in AMKL pathogenesis.